Novartis Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 2,125,538 | 0.104% |
Private Companies | 89,202,482 | 4.37% |
Institutions | 655,688,600 | 32.1% |
General Public | 1,293,389,767 | 63.4% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
89,135,960 | AR$7.6t | 0% | no data | |||
83,366,457 | AR$7.1t | 1.55% | 0.14% | |||
61,129,038 | AR$5.2t | 8.98% | 0.87% | |||
54,918,539 | AR$4.7t | 1.43% | 0.47% | |||
50,178,623 | AR$4.3t | 1.71% | 3.62% | |||
42,984,747 | AR$3.7t | -1.6% | 0.72% | |||
17,436,123 | AR$1.5t | 0% | 1.29% | |||
17,094,202 | AR$1.5t | -0.12% | 1.36% | |||
14,157,452 | AR$1.2t | 1.16% | 0.12% | |||
13,406,616 | AR$1.1t | 3.08% | 0.9% | |||
12,169,577 | AR$1.0t | 0.01% | 0.76% | |||
11,447,116 | AR$979.6b | 0% | 9.3% | |||
8,360,148 | AR$715.5b | 12.3% | 0.18% | |||
8,328,042 | AR$712.7b | 0% | 0.1% | |||
8,036,452 | AR$687.8b | 15.8% | 5.76% | |||
7,439,661 | AR$636.7b | 4.69% | 0.16% | |||
7,294,846 | AR$624.3b | -3.06% | 0.04% | |||
6,378,810 | AR$545.9b | 1.16% | 0.27% | |||
6,359,661 | AR$544.3b | -0.09% | 0.03% | |||
6,216,480 | AR$532.0b | 3.93% | 1.51% | |||
6,114,340 | AR$523.3b | 2.34% | 0.11% | |||
5,455,974 | AR$466.9b | -0.92% | 0.05% | |||
5,359,261 | AR$458.6b | -0.29% | 0.5% | |||
5,333,245 | AR$456.4b | 0.19% | 0.27% | |||
4,623,737 | AR$395.7b | 0% | 0.42% |